이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
CONMED 관리
관리 기준 확인 3/4
CONMED's CEO는 Curt Hartman, Jul2014 에 임명되었습니다 의 임기는 9.92 년입니다. 총 연간 보상은 $ 7.76M, 12.2% 로 구성됩니다. 12.2% 급여 및 87.8% 보너스(회사 주식 및 옵션 포함). 는 $ 5.92M 가치에 해당하는 회사 주식의 0.29% 직접 소유합니다. 5.92M. 경영진과 이사회의 평균 재임 기간은 각각 9.1 년과 8.9 년입니다.
주요 정보
Curt Hartman
최고 경영자
US$7.8m
총 보상
| CEO 급여 비율 | 12.2% |
| CEO 임기 | 10.2yrs |
| CEO 소유권 | 0.3% |
| 경영진 평균 재임 기간 | 8yrs |
| 이사회 평균 재임 기간 | 9.2yrs |
최근 관리 업데이트
Recent updates
Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price
Sep 12
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20
Aug 15CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price
Jul 17AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation
Jun 21There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding
Jun 01Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
Feb 15US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
Feb 03Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?
Jan 08Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects
Dec 18CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Oct 28Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
Sep 22Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly
Jul 28Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?
Jun 08These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Apr 28Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Mar 10Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M
Feb 02Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Jan 24ConMed: Still Fairly Priced, Turning More Constructive
Dec 09At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?
Nov 18Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet
Oct 11ConMed: Fairly Priced At Pre-Pandemic Market Cap
Sep 21CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20
Sep 03CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20
Aug 18CONMED declares $0.20 dividend
Aug 11CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$99m |
| Mar 31 2024 | n/a | n/a | US$82m |
| Dec 31 2023 | US$8m | US$950k | US$64m |
| Sep 30 2023 | n/a | n/a | US$58m |
| Jun 30 2023 | n/a | n/a | US$88m |
| Mar 31 2023 | n/a | n/a | -US$94m |
| Dec 31 2022 | US$8m | US$946k | -US$81m |
| Sep 30 2022 | n/a | n/a | -US$83m |
| Jun 30 2022 | n/a | n/a | -US$114m |
| Mar 31 2022 | n/a | n/a | US$68m |
| Dec 31 2021 | US$9m | US$918k | US$63m |
| Sep 30 2021 | n/a | n/a | US$62m |
| Jun 30 2021 | n/a | n/a | US$54m |
| Mar 31 2021 | n/a | n/a | US$13m |
| Dec 31 2020 | US$6m | US$888k | US$10m |
| Sep 30 2020 | n/a | n/a | US$311k |
| Jun 30 2020 | n/a | n/a | US$431k |
| Mar 31 2020 | n/a | n/a | US$34m |
| Dec 31 2019 | US$6m | US$842k | US$29m |
| Sep 30 2019 | n/a | n/a | US$29m |
| Jun 30 2019 | n/a | n/a | US$28m |
| Mar 31 2019 | n/a | n/a | US$31m |
| Dec 31 2018 | US$5m | US$791k | US$41m |
| Sep 30 2018 | n/a | n/a | US$72m |
| Jun 30 2018 | n/a | n/a | US$73m |
| Mar 31 2018 | n/a | n/a | US$71m |
| Dec 31 2017 | US$3m | US$753k | US$55m |
보상 대 시장: Curt 의 총 보상 ($USD 7.76M )은 US 시장( $USD 5.67M ).
보상과 수익: Curt 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Curt Hartman (60 yo)
10.2yrs
테뉴어
US$7,764,615
보상
Mr. Curt R. Hartman has been Chairman of the Board at CONMED Corporation since May 21, 2020. Mr. Hartman has been the Chief Executive Officer and President of CONMED Corporation since November 09, 2014. Mr...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman of the Board | 10.2yrs | US$7.76m | 0.28% $ 6.6m | |
| Executive VP of Finance & CFO | 6.7yrs | US$2.87m | 0.00074% $ 17.1k | |
| Chief Operating Officer | less than a year | US$3.30m | 0.035% $ 807.8k | |
| President of Advanced Surgical & Advanced Endoscopic Technologies | 9.7yrs | US$2.00m | 0.0048% $ 111.1k | |
| Chief Information Officer | no data | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Strategy & Corporate Development | 9.3yrs | 데이터 없음 | 0.012% $ 277.5k | |
| Executive VP of Information Technology & CIO | 4.5yrs | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Human Resources | 1.8yrs | 데이터 없음 | 0.0023% $ 52.5k | |
| Special Counsel & Corporate Secretary | 6.3yrs | US$1.55m | 0.044% $ 1.0m | |
| President of ConMed Electrosurgery | 20.2yrs | US$572.33k | 데이터 없음 | |
| VP of Tax & Treasurer | 9.4yrs | 데이터 없음 | 0.0043% $ 98.4k |
8.0yrs
평균 재임 기간
56yo
평균 연령
경험이 풍부한 관리: CNMD 의 관리팀은 노련하고 경험 (평균 재직 기간 9.1 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman of the Board | 10.5yrs | US$7.76m | 0.28% $ 6.6m | |
| Independent Director | 9.2yrs | US$257.37k | 0.066% $ 1.5m | |
| Independent Director | 9.2yrs | US$264.87k | 0.054% $ 1.3m | |
| Independent Director | 11.2yrs | US$257.37k | 0.031% $ 720.5k | |
| Independent Director | 4.8yrs | US$257.37k | 0.012% $ 266.9k | |
| Lead Independent Director | 8.6yrs | US$292.37k | 0.045% $ 1.0m | |
| Independent Director | 10.2yrs | US$249.87k | 0.066% $ 1.5m | |
| Independent Director | 5yrs | US$264.87k | 0.017% $ 396.7k |
9.2yrs
평균 재임 기간
64yo
평균 연령
경험이 풍부한 이사회: CNMD 의 이사회는 경험(평균 재직 기간 8.9 년)으로 간주됩니다.